Table 2 Pathology results
Pathological types | Uniportal VATS (%) (n = 73) | Two-port VATS (%) (n = 86) | Three-port VATS (%) (n = 98) | P-value |
|---|---|---|---|---|
Primary lung cancer | 51 (69.86%) | 56 (65.12%) | 71 (72.45%) | 0.556 |
Adenocarcinoma | 34 (46.58%) | 38 (44.19%) | 52 (53.06%) | 0.459 |
Squamous cell carcinoma | 16 (21.92%) | 15 (17.44%) | 13 (13.27%) | 0.330 |
Adenosquamous | 0 (0%) | 1 (1.16%) | 1 (1.02%) | 1.000 |
Large cell carcinoma | 1 (1.37%) | 0 (0%) | 2 (2.04%) | 0.506 |
Carcinoid tumors | 0 (0%) | 1 (1.16%) | 0 (0%) | 0.619 |
Carcinosarcoma | 0 (0%) | 0 (0%) | 1 (1.02%) | 1.000 |
Small cell carcinoma | 0 (0%) | 1 (1.16%) | 2 (2.04%) | 0.780 |
Benign disease | 22 (30.14%) | 30 (34.88%) | 27 (27.55%) | 0.556 |
Inflammation | 3 (4.11%) | 6 (6.98%) | 7 (7.14%) | 0.676 |
Pulmonary cyst | 4 (5.48%) | 4 (4.65%) | 4 (4.08%) | 0.933 |
Tuberculosis | 4 (5.48%) | 9 (10.47%) | 7 (7.14%) | 0.482 |
Pulmonary hamartoma | 2 (2.74%) | 3 (3.49%) | 3 (3.06%) | 1.000 |
Pulmonary fibrosis | 4 (5.48%) | 3 (3.49%) | 1 (1.02%) | 0.223 |
Bronchiectasis | 5 (6.85%) | 4 (4.65%) | 4 (4.08%) | 0.723 |
Lung sequestration | 0 (0%) | 0 (0%) | 1 (1.02%) | 1.000 |
Spindle cell lipoma | 0 (0%) | 1 (1.16%) | 0 (0%) | 0.619 |